Hirtle Callaghan & Co’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-39
Closed -$6K 60
2019
Q1
$6K Buy
+39
New +$5.45K ﹤0.01% 47
2018
Q2
Sell
-41
Closed -$5K 122
2018
Q1
$5K Hold
41
﹤0.01% 110
2017
Q4
$6K Buy
+41
New +$5.5K ﹤0.01% 119
2016
Q1
Sell
-2,244
Closed -$209K 178
2015
Q4
$209K Buy
2,244
+453
+25% +$41.5K 0.05% 54
2015
Q3
$152K Sell
1,791
-960
-35% -$87.4K 0.03% 96
2015
Q2
$252K Buy
+2,751
New +$257K 0.09% 59
2014
Q3
Sell
-4,674
Closed -$390K 589
2014
Q2
$390K Sell
4,674
-779
-14% -$65.1K 0.05% 166
2014
Q1
$455K Sell
5,453
-278
-5% -$23K 0.08% 136
2013
Q4
$471K Sell
5,731
-1,113
-16% -$87K 0.06% 138
2013
Q3
$511K Buy
+6,844
New +$508K 0.08% 127

Other funds holding HON

Hirtle Callaghan & Co's HON Position: Q2 2019 in Review

Hirtle Callaghan & Co sold out of Honeywell (HON) in Q2 2019, closing a stake of 39 shares — an estimated $6K sold.

Hirtle Callaghan & Co first reported a position in HON in Q3 2013 and held it in 10 quarters. The position peaked at $511K in Q3 2013. 1,897 funds tracked by Wall St. Rank hold HON as of Q2 2019.

  • Hirtle Callaghan & Co reported no remaining Honeywell position as of Q2 2019 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 39 Honeywell shares in Q2 2019, an estimated $6K.
  • Hirtle Callaghan & Co first reported a position in Honeywell in Q3 2013 and held it in 10 quarters.
  • Hirtle Callaghan & Co's Honeywell position peaked at $511K in Q3 2013.
  • 1,897 funds tracked by Wall St. Rank held Honeywell as of Q2 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2019, filed 13 Aug 2019.